Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
18 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05592132 | Use of Virtual Reality in Pain Management in Pediatric Oncology(DOREVI) | recruiting | N/A | 74 | Centre Hospitalier Universitaire de la RéunionOTHER | 1 | Sep 11, 2026 | clinicaltrials |
| NCT01689584 | COsegregation of VARiants in Panel of Genes(COVAR) | recruiting | N/A | 11,000 | Institut CurieOTHER | 5 | Sep 1, 2026 | clinicaltrials |
| NCT03293563 | UroCCR Database: French Research Network for Kidney Cancer -UroCCR(UroCCR) | recruiting | — | 30,000 | University Hospital, BordeauxOTHER | 4 | Jun 25, 2026 | clinicaltrials |
| NCT03570021 | ESTIMation of the ABiLity of Prophylactic Central Compartment Neck Dissection to Modify Outcomes in Low-risk Differentiated Thyroid Cancer(ESTIMABL3) | active not recruiting | Phase 3 | 352 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 3 | Mar 6, 2026 | clinicaltrials |
| NCT07344844 | Adaptive Stereotactic Radiotherapy for Localized Prostate Cancer(SPAR) | recruiting | N/A | 100 | Clinique Sainte ClotildeOTHER | 1 | Jan 15, 2026 | clinicaltrials |
| NCT06507917 | Concordance and Acceptability of Self-screening Versus Screening by a Healthcare Professional for HPV, a Risk Factor for Anal Cancer, by Swab in People Living With HIV(a-HPVVIH) | recruiting | N/A | 398 | Centre Hospitalier Universitaire de la RéunionOTHER | 1 | Dec 11, 2025 | clinicaltrials |
| NCT03356171 | Cardiac Coherence Combined With Personal Physical Activity in Patients With Cancer(APACCHE) | completed | N/A | 80 | Centre Hospitalier Universitaire de la RéunionOTHER | 1 | Oct 2, 2025 | clinicaltrials |
| NCT06207981 | Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy for Locally Advanced SCCA(KANALRAD) | recruiting | Phase 3 | 310 | Federation Francophone de Cancerologie DigestiveOTHER | 2 | Sep 2, 2025 | clinicaltrials |
| NCT03472807 | EXOme Rare Cancers in Children (EXOCARE)(EXOCARE) | terminated | N/A | 169 | University Hospital, AngersOTHER_GOV | 2 | Mar 17, 2025 | clinicaltrials |
| NCT04934475 | MInimal Residual Disease Adapted Strategy(MIDAS) | active not recruiting | Phase 3 | 791 | Intergroupe Francophone du MyelomeNETWORK | 3 | Nov 7, 2024 | clinicaltrials |
| NCT06393816 | FIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and Platinum(FIRST-NEC) | recruiting | Phase 2 | 80 | Centre Leon BerardOTHER | 2 | Aug 2, 2024 | clinicaltrials |
| NCT05367180 | The Impact of a Prevention Program on Sun Risks in Primary School in Tropical French Region(PRESOLRE) | completed | N/A | 1,452 | Centre Hospitalier Universitaire de la RéunionOTHER | 1 | Feb 29, 2024 | clinicaltrials |
| NCT02900287 | Cancer Survival in Reunion Island , 1998-2008 (SUCRE)(SUCRE) | completed | — | 18,000 | Centre Hospitalier Universitaire de la RéunionOTHER | 1 | Jan 5, 2024 | clinicaltrials |
| NCT04261725 | Prevalence of EGFR Mutations in epidermoïd Bronchopulmonary Cancers in Réunion Island(EPIMURE) | completed | — | 60 | Centre Hospitalier Universitaire de la RéunionOTHER | 1 | Jan 10, 2023 | clinicaltrials |
| NCT04932681 | Use of Medicinal Plants and Other Alternative and Complementary Medicines by Patients With Cancer in Reunion Island(CAMUCRI) | unknown | — | 520 | Centre Hospitalier Universitaire de la RéunionOTHER | 1 | Apr 8, 2022 | clinicaltrials |
| NCT04453384 | Study to Evaluate the Safety and Efficacy of XAV-19 in Patients With COVID-19 Induced Moderate Pneumonia(POLYCOR) | completed | Phase 2 | 416 | Nantes University HospitalOTHER | 3 | Mar 25, 2022 | clinicaltrials |
| NCT04298684 | Efficacy of Metformin Versus Sitagliptin on Benign Thyroid Nodules in Type 2 Diabetes(METNODTHYR) | unknown | Phase 4 | 90 | Centre Hospitalier Universitaire de la GuadeloupeOTHER | 3 | Sep 11, 2020 | clinicaltrials |
| NCT00401323 | Taxotere (Docetaxel) in 1st Line Treatment of Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma | completed | Phase 2 / Phase 3 | 568 | SanofiINDUSTRY | 20 | Jan 20, 2011 | clinicaltrials |
Data updated 18 days agoSource updated unknownsource: clinicaltrials